Article
[Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Dec 2022
Su L, Tan Y H, Lin H, Han W, Yang Y P, Liu X L, Sun J N, Liu Q J, Gao S J
Abstract excerpt
Objective: This investigation aims to assess the impact of CSF3R mutations and the presence of measurable residual disease (MRD) on the prognosis of patients with CEBPA double mutations who have acute myeloid leukemia (AML) . Methods: The prognostic significance of these two factors was examined in the present study, which included 66 patients with complete genetic mutations and sequential MRD information....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.